1,3-Bis(2-thienylmethyl)-4,5-dihydroimidazolium trichlorido(?6-p-cymene) ruthenate(II)

dc.authoridÖzdemir, İsmail/0000-0001-6325-0216
dc.authoridGurbuz, Nevin/0000-0003-3201-3597
dc.authoridArslan, Hakan/0000-0003-0046-9442
dc.authoridCetinkaya, Bekir/0000-0002-4551-8650
dc.authorwosidÖzdemir, İsmail/ABI-5192-2020
dc.authorwosidGurbuz, Nevin/A-3069-2016
dc.authorwosidArslan, Hakan/B-1081-2008
dc.authorwosidGök, Yetkin/AAA-5669-2021
dc.contributor.authorArslan, Hakan
dc.contributor.authorVanDerveer, Don
dc.contributor.authorOzdemir, Ismail
dc.contributor.authorGurbuz, Nevin
dc.contributor.authorGok, Yetkin
dc.contributor.authorCetinkaya, Bekir
dc.date.accessioned2024-08-04T20:31:08Z
dc.date.available2024-08-04T20:31:08Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe asymmetric unit of the title compound, (C13H15N2S2)-[RuCl3(C10H14)], contains a 1,3-(2-thienylmethyl)-4,5-dihydroimidazolium cation and a trichlorido(eta(6)-p-cymene)ruthenate(II) anion. The thiophene rings of the cation are disordered by an 180 degrees rotation about the thiophene-CH2 bonds with occupancies of 0.847 (5)/0.153 (5) and 0.700 (5)/0.300 (5), respectively. The Ru atom exhibits a distorted octahedral coordination with the benzene ring of the p-cymene ligand formally occupying three sites and three Cl atoms occupying the other three sites. The short C-N bond lengths in the imidazoline ring indicate partial electron delocalization within the N-C-N fragment. Cation and anions are connected through five intermolecular C-H center dot center dot center dot Cl hydrogen bonds and one C-H center dot center dot center dot pi hydrogen bond, forming a three-dimensional hydrogen-bonded network.en_US
dc.description.sponsorshipTechnological and Scientific Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)]; Inonu University Research Fund [BAP: 2008-Gudumlu3]en_US
dc.description.sponsorshipWe thank the Technological and Scientific Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)] and Inonu University Research Fund (BAP: 2008-Gudumlu3) for financial support.en_US
dc.identifier.doi10.1107/S1600536809000464
dc.identifier.endpageU492en_US
dc.identifier.issn2056-9890
dc.identifier.pmid21581774en_US
dc.identifier.scopus2-s2.0-60349105658en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageM165en_US
dc.identifier.urihttps://doi.org/10.1107/S1600536809000464
dc.identifier.urihttps://hdl.handle.net/11616/94752
dc.identifier.volume65en_US
dc.identifier.wosWOS:000263040700038en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherInt Union Crystallographyen_US
dc.relation.ispartofActa Crystallographica Section E-Crystallographic Communicationsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectN-Heterocyclic Carbenesen_US
dc.subjectComplexesen_US
dc.subjectCatalystsen_US
dc.subjectArylationen_US
dc.title1,3-Bis(2-thienylmethyl)-4,5-dihydroimidazolium trichlorido(?6-p-cymene) ruthenate(II)en_US
dc.typeArticleen_US

Dosyalar